Main public logs
Jump to navigation
Jump to search
Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 20:32, 12 February 2024 Fire talk contribs created page aclacinomycin T methylesterase activity (Q20872) (wbeditentity-create:2|en: aclacinomycin T methylesterase activity, Catalysis of the reaction: aclacinomycin T(1+) + H2O <=> 15-demethylaclacinomycin T + methanol + H+)
- 20:31, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/10/ja (Created page with "下肢切断のリスク増加はカナグリフロジンと関連しているが、異なるグリフロジンに関連するこのリスクを確認するためにはさらなるデータが必要である。欧州医薬品庁のレビューでは、カナグリフロジン、ダパグリフロジン、エンパグリフロジンを服用している患者では、下肢切断(主に足指に影響)のリス...")
- 20:29, 12 February 2024 Fire talk contribs created page diphthine methylesterase activity (Q20871) (wbeditentity-create:2|en: diphthine methylesterase activity, Catalysis of the reaction: diphthine methyl ester + H2O <=> diphthine + H+ + methanol.)
- 20:28, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/9/ja (Created page with "2015年9月、FDAはカナグリフロジン(インボカーナ)およびカナグリフロジン/メトホルミン(インボカメット)に関連し、骨密度が低下するため骨折のリスクが高まるとして警告を発した。グリフロジンとメトホルミンの併用療法は、スルホニル尿素やインスリンなどの他の2型糖尿病治療薬と比較して、低血糖のリスクを低下させる。")
- 20:27, 12 February 2024 Fire talk contribs created page polyneuridine-aldehyde esterase activity (Q20870) (wbeditentity-create:2|en: polyneuridine-aldehyde esterase activity, Catalysis of the reaction: H(2)O + polyneuridine aldehyde = 16-epivellosimine + CO(2) + methanol.)
- 20:26, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/8/ja (Created page with "2015年5月、FDAはグリフロジンが糖尿病性ケトアシドーシス(DKA、体内でケトン体と呼ばれる血中酸が大量に生成される重篤な状態)のリスクを高める可能性があるとの警告を発した。グルコースの血液循環を減少させることにより、グリフロジンは糖尿病性ケトアシドーシスを引き起こす内因性インスリン分泌の...")
- 20:22, 12 February 2024 Fire talk contribs created page methanol dehydrogenase activity (Q20869) (wbeditentity-create:2|en: methanol dehydrogenase activity, Catalysis of the reaction: methanol + NAD(+) = formaldehyde + H(+) + NADH.)
- 20:21, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/7/ja (Created page with "==副作用== {{Anchor|Adverse effects}} グリフロジンの副作用としては生殖器感染症が最も多いようである。臨床試験では、真菌感染症、尿路感染症、浸透圧利尿がグリフロジン投与患者で高かった。")
- 20:20, 12 February 2024 Fire talk contribs created page 4-methyloxaloacetate esterase activity (Q20868) (wbeditentity-create:2|en: 4-methyloxaloacetate esterase activity, Catalysis of the reaction: 4-methoxy-2,4-dioxobutanoate + H(2)O = H(+) + methanol + oxaloacetate.)
- 20:19, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/6/ja (Created page with "2つのレビューで、SGLT2阻害薬はアテローム性動脈硬化症の主要有害心血管イベント(MACE)患者に有益であると結論されている。そのうちの1つの研究では、MACEを心筋梗塞、脳卒中、心血管死の複合と定義した。")
- 20:16, 12 February 2024 Fire talk contribs created page methanol-5-hydroxybenzimidazolylcobamide Co-methyltransferase activity (Q20867) (wbeditentity-create:2|en: methanol-5-hydroxybenzimidazolylcobamide Co-methyltransferase activity, Catalysis of the reaction: 5-hydroxybenzimidazolylcobamide + methanol = H2O + Co-methyl-Co-5-hydroxybenzimidazolylcob(I)amide.)
- 20:15, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/5/ja (Created page with "13の心血管アウトカム試験を含むメタアナリシスによると、SGLT-2阻害薬は、特に推算糸球体濾過量(eGFR)が60ml/分未満の被験者において、3点MACEのリスクを低下させるが、GLP-1受容体作動薬はeGFRが高い人ほど有益であった。同様に、SGLT-2阻害薬によるリス...")
- 20:13, 12 February 2024 Fire talk contribs created page pheophorbidase activity (Q20866) (wbeditentity-create:2|en: pheophorbidase activity, Catalysis of the reaction: pheophorbide a + H2O = pyropheophorbide a + methanol + CO2. The reaction occurs in two steps; pheophoridase catalyzes the conversion of pheophorbide a to a precursor of pyropheophorbide a, C-13(2)-carboxylpyropheophorbide a)
- 20:13, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/4/ja (Created page with "SGLT-2阻害薬、GLP-1作動薬、およびDPP-4阻害薬を比較したシステマティックレビューとネットワークメタ解析では、SGLT2阻害薬の使用は、プラセボまたは無治療と比較して死亡の20%減少と関連していることが示された。別の系統的レビューでは、SGLT-2阻害薬が2型...")
- 20:10, 12 February 2024 Fire talk contribs created page juvenile-hormone esterase activity (Q20865) (wbeditentity-create:2|en: juvenile-hormone esterase activity, Catalysis of the reaction: methyl (2E,6E)-(10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate + H2O = (2E,6E)-(10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate + methanol. A carboxylesterase that hydrolyzes the ester linkage of juveni)
- 20:08, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/3/ja (Created page with "==医薬用途== {{Anchor|Medical uses}} 2022年のADAの糖尿病診療標準では、SGLT2阻害薬は2型糖尿病のファーストライン薬物療法として(通常はメトホルミンと併用する)、特に慢性腎臓病、心血管疾患、心不全を有する患者に使用されている。")
- 19:56, 12 February 2024 Fire talk contribs created page hydrogen metabolic process (Q20864) (wbeditentity-create:2|en: hydrogen metabolic process, chemical reactions and pathways involving H2 (dihydrogen))
- 19:55, 12 February 2024 Fire talk contribs created page methane biosynthetic process from methanol and hydrogen (Q20863) (wbeditentity-create:2|en: methane biosynthetic process from methanol and hydrogen, The chemical reactions and pathways resulting in the formation of methane from methanol and hydrogen.)
- 19:53, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/2/ja (Created page with "'''SGLT2阻害薬'''は、'''グリフロジン'''または'''フロジン'''とも呼ばれ、腸管粘膜で同様の機能を果たすSGLT1阻害薬とは異なり、ネフロン(腎臓の機能単位)におけるナトリウム-グルコース輸送タンパク質を阻害する医薬品の一種である。この代謝作用の最たるものは、renal...")
- 19:48, 12 February 2024 Fire talk contribs created page response to methanol (Q20862) (wbeditentity-create:2|en: response to methanol, Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methanol stimulus.)
- 19:47, 12 February 2024 Fire talk contribs created page SGLT2 inhibitor/ja (Created page with "SGLT2阻害剤")
- 19:47, 12 February 2024 Fire talk contribs created page cellular response to methanol (Q20861) (wbeditentity-create:2|en: cellular response to methanol, Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methanol stimulus.)
- 19:46, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/1/ja (Created page with "{{Drug List/ja|state6=uncollapsed}} {{Pathnav|Medication/ja|Diabetes medication/ja|frame=1}} {| class="wikitable sortable" style="width:100%" |- !一般名 !先発名 !class="unsortable"| 日本 !創薬/開発 !備考 |- |イプラグリフロジン |[https://amn.astellas.jp/di/detail/sgl/index_sgl-25 スーグラ](Sugulat) ([https://amn.astellas.jp/common/pdfviewer.html/content/dam/jp/amn/jp/ja/di/doc/Pdfs/DocNo202211124_y.pdf PI]) ([https://amn.astellas.jp/common/pdfviewer.ht...")
- 19:46, 12 February 2024 Fire talk contribs created page Translations:SGLT2 inhibitor/Page display title/ja (Created page with "SGLT2阻害剤")
- 19:46, 12 February 2024 FuzzyBot talk contribs created page SGLT2 inhibitor/en (Updating to match new version of source page) Tags: Mobile edit Mobile web edit
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/45/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/44/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/43/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/42/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/41/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/40/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/39/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/38/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/37/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/36/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/35/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/34/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/33/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/32/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/31/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/30/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/29/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/28/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/27/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/26/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/25/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/24/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/23/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/22/en (Importing a new version from external source)
- 19:46, 12 February 2024 FuzzyBot talk contribs created page Translations:SGLT2 inhibitor/21/en (Importing a new version from external source)